UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 11, 2017
Accession Number:
Submission Type:
CIK: 0001550518
Company Name: Cantabio Pharmaceuticals Inc.
File Number: 333-217749